FORWARD FEATURES CALENDAR

Deals & Transactions

Portobello Capital acquires Farmol

Spanish private equity firm Portobello Capital has acquired a 100 per cent stake in Farmol, a leading contract manufacturer of aerosol and liquid branded products for Personal Care, Home Care, and Health Care in Europe. Founded in 1946 and based in Comun Nuovo (Italy), Farmol is one of the leading

BGF sees business confidence grow in 2021

BGF is reporting a strong outlook for 2021. Throughout the last six months, the investment team for Scotland has invested close to GBP33 million across 10 Scottish growth businesses, including a cornerstone investment which marked BGF’s second investment in a Scottish IPO in 12 months. BGF is a long-term patient

Astorg and Bridgepoint complete Fenergo acquisition

Astorg and Bridgepoint have completed their acquisition of Fenergo, a provider of Know Your Customer (KYC) and Client Lifecycle Management (CLM) software solutions for financial institutions, following approval by the European Commission.  Entering its third chapter of growth, Fenergo reinforces its commitment to developing innovative, digital solutions that equip financial

ARQIS advises Liberta Partners on the sale of novelex AG

ARQIS has advised Liberta Partners on the sale of novelex AG to H&T Presspart, a division of Heitkamp & Thumann Group.  The company, headquartered in Nidau, Switzerland, is a specialist in the design, development and manufacture of complex total plastic solutions for the pharmaceutical, diagnostics and medical technology industries.  

Wynnchurch Capital acquires Trimlite

Wynnchurch Capital has acquired Trimlite, a manufacturer and distributor of residential doors and related door products.  Founded in 1982 and headquartered in Renton, Washington, Trimlite has developed a strong presence in the US and Canada by providing high quality products and value-added services to its diverse network of wholesale distributors,

Topas Therapeutics extends Series B by EUR18m to EUR40m total

Topas Therapeutics GmbH (Topas), a private biotechnology company developing immune tolerance-inducing drugs to treat and potentially cure a variety of autoimmune diseases, today announced that the Company has successfully extended its Series B round with an additional EUR18 million (~USD22 million) raised, bringing the total for this financing to EUR40

SPAC Queen’s Gambit to acquire mass transit platform Swvl

Queen’s Gambit Growth Capital (Queen’s Gambit), the first special purpose acquisition company (SPAC) led by women, is to acquire Swvl, a Dubai-based provider of transformative mass transit and shared mobility solutions, in a deal that will see Swvl becoming a publicly listed company.  Upon completion of the proposed transaction, the

Events

12 November, 2026 – 5:00 pm

Directory Listings